NCT05021120
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05021120
Title A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Akeso
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Ashford Cancer Centre Research Adelaide Australia Details
Austin Health Melbourne Australia Details
Monash Health Melbourne Australia Details
Southside Cancer Care Centre Sydney Australia Details
The Kinghorn Cancer Centre, St Vincents Hospital Sydney Sydney Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field